{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:39:56Z","timestamp":1768005596408,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.urolonc.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:21:44Z","timestamp":1568420504000},"page":"77.e1-77.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?"],"prefix":"10.1016","volume":"38","author":[{"given":"Francesco","family":"Soria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-1077","authenticated-orcid":false,"given":"David","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-8613","authenticated-orcid":false,"given":"Simone","family":"Mazzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pizzuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.08.010_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update","volume":"71","author":"Babjuk","year":"2016","journal-title":"Eur Urol n.d"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0003","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC Nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage ta-t1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0006","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/nrurol.2017.125","article-title":"Characteristics and clinical significance of histological variants of bladder cancer","volume":"14","author":"Moschini","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0008","article-title":"Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: a clinical decision-making tool","author":"D'Andrea","year":"2018","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0009","first-page":"293","article-title":"A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer","volume":"36","author":"Mari","year":"2018","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with bacillus calmette-gu??rin: results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-018-2299-2","article-title":"Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought","author":"Palou","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0012","first-page":"1","article-title":"The impact of re-TUR on clinical outcomes in a large multi-centre cohort of T1-HG\/G3 patients treated with BCG","author":"Gontero","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0013","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","article-title":"Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Gu\u00e9rin","volume":"38","author":"Angulo","year":"2014","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0014","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2016.01.004","article-title":"\u201cEn Bloc\u201d resection of nonmuscle invasive bladder cancer: a prospective single-center study","volume":"90","author":"Hurle","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0016","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1464-410X.2010.09217.x","article-title":"International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","article-title":"Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"49","author":"Xylinas","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0018","doi-asserted-by":"crossref","DOI":"10.21037\/tau.2018.10.19","article-title":"The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer","author":"Soria","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0019","article-title":"Role of restaging transurethral resection for t1 non-muscle invasive bladder cancer: a systematic review and meta-analysis","author":"Naselli","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non\u2013muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0021","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bju.14557","article-title":"Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour","volume":"123","author":"Suarez-Ibarrola","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0022","first-page":"40.e17","article-title":"Presence of detrusor muscle in bladder tumor specimens\u2014predictors and effect on outcome as a measure of resection quality","volume":"32","author":"Shoshany","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000341103","article-title":"Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue","volume":"89","author":"Huang","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0025","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.7150\/jca.26129","article-title":"Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade\/grade 3 bladder cancer","volume":"9","author":"Ferro","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0026","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0974-7796.140990","article-title":"Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer","volume":"6","author":"Gill","year":"2014","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1089\/end.2016.0534","article-title":"En Bloc transurethral resection of bladder tumors: a new standard?","volume":"31","author":"Naselli","year":"2017","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2019.08.010_bib0028","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.euf.2016.12.004","article-title":"Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer","volume":"3","author":"Kramer","year":"2017","journal-title":"Eur Urol Focus"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391930328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391930328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:17Z","timestamp":1761041897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391930328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S107814391930328X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.08.010","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}